STATEMENT
As Vice Chair of AmCham Dubai, I’ve worked to strengthen our governance, elevate our advocacy efforts, and ensure that our programs truly serve our members and partners. Over the past term (and the 15 years prior as a member of the AmCham organization), I’ve helped drive more strategic engagement with the U.S. business community, foster deeper collaboration with local institutions, and position AmCham as a trusted voice on economic growth and innovation in the region.
With my continued commitment to purposeful leadership, strong governance, and tangible results, I believe I can help the AmCham continue to build on its momentum and shape a more connected and influential future for our members, both within the general business community and specifically in the healthcare vertical that I am so deeply and passionately involved with.
ABOUT
Robert Mikhael: General Manager & Head of Emerging Markets, Cardiometabolic - Abbott
Robert Mikhael is a veteran of the pharma and healthcare industries with over 22+ years of varied experience. He started his career with Pfizer in 2003 when he joined the NY HQ as a Senior Projects Analyst within the CIT application hosting group. He’s held positions of Lead Architect, Team Leader and Global Manager before moving to the Middle East Region in 2006.
Robert took on multiple roles of increasing responsibility across various business units while part of the Africa and Middle East (AfME) organization, including AfME Pfizer Innovative Health (PIH) Director of Business Operations, where he was responsible for all business operations/strategic projects for the PIH organization and Chief of Staff and Integration Lead for the Emerging Markets segment. In his last role in Pfizer he was General Manager for the Sub-Saharan Africa, India and Pakistan Cluster (PSI). Prior to moving as Head of Business Transformation and Integration, and then as Regional President of the North Africa, Egypt, Russia and CIS Markets (NARUCIS) for Viatris, Robert was directly responsible for the overall general management of the cluster, including setting the strategic approach, day to day performance management of 600+ colleagues, and external stakeholder engagement to shape policy improvements in over a dozen countries.
In his current role as Regional Managing Director and Head of the Global Emerging Markets for the Cardiometabolic Division at Abbott, Robert is tasked with the growth and management of divisional operations spanning Canada, Latin America, Africa and the Middle East, Eastern Europe, India, Emerging Asia and China.
Robert has a Bachelors Degree in Biochemistry from New York University, a Masters of Science in Management and an MBA from the Stevens Institute of Technology, a Masters of Science in Applied Research and has completed post-graduate studies at the Harvard Business School. He is also the Executive Vice President for the AmCham (American Chamber) of Dubai and the Northern Emirates, as well as a Board Director for the Harvard Business School Club of the GCC. Robert lives in Dubai with his wife Diana, and two young boys – Henry and Harvey.